Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ).
Concord Healthcare Group Co., Ltd. reported that its annual general meeting in Beijing on May 11, 2026, proceeded in line with PRC company law and its articles of association, with shareholders holding about 42% of issued shares in attendance. All directors participated in person or electronically, and the poll was overseen by the company’s H share registrar to ensure orderly vote-taking.
Shareholders overwhelmingly approved all ordinary resolutions, including the 2025 directors’ report and annual report, director remuneration for 2025 and proposed remuneration for 2026, reappointment of the auditor, the 2025 ESG report, and the 2025 annual results announcement and related authorisations. The meeting also endorsed the decision not to pay a final dividend and confirmed the appointment and 2026 remuneration of a new executive director, signaling strong investor support for the current governance and capital allocation stance.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a healthcare services provider based in the People’s Republic of China and listed in Hong Kong. The company operates within the medical and hospital services sector, serving both domestic and international investors through its H shares and domestic share structure.
Average Trading Volume: 510,930
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.17B
For detailed information about 2453 stock, go to TipRanks’ Stock Analysis page.